“…The current standard of care for warfarin oral anticoagulant therapy, as dictated by the American Society of Hematology, is an expert-system type algorithm that provides no dosing personalization and also does not explicitly optimize the monitoring frequency of the efficacy of the therapy (Cushman, Lim, & Zakai, 2011). While there are many other warfarin dosing algorithms that seek to improve the efficacy of warfarin therapy, including pharmacogenetic algorithms (Carlquist & Anderson, 2011) and computerized algorithms (Grzymala-Lubanski, Själander, Renlund, Svensson, & Själander, 2013;Dimberg, et al, 2012), these algorithms do a poor job of accounting for intra-patient variability (Kangelaris, Bent, Nussbaum, Garcia, & Tice, 2009) and do not explicitly optimize the monitoring frequency, which would reduce the overall cost of the therapy. Intra-patient variability during maintenance dosing can occur due to a variety of factors such as diet, disease state, and drug interactions.…”